GLA p.Trp47Arg
c.139T>C · VCV3340290
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9591 | likely pathogenic ✓ concordant with ClinVar · top 3% in GLA |
|---|---|---|
| REVEL | 0.961 | strongly pathogenic-leaning |
| SaProt | LLR -12.67 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 11 | GERP 3.4, phastCons 1 |
| Regional constraint | o/e 0.25 | constrained · MANE · 3,899 bp · p 4.8e-07 · regional, not allelic |
| Overall | ||
| CADD | 29.6 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- GLA
- Protein
- p.Trp47Arg
- Coding
- c.139T>C
- MANE Select
- NM_000169
- Type
- single nucleotide variant
- Location
- chrX:101407765 (GRCh38)
- Structure
- AlphaFold pLDDT 94.45 · 31 PDB
- Residue 47
- an α-helix; a UniProt-annotated variant site (in fabryd; decreased alpha-galactosidase activity)
Disease context
Fabry disease — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Fabry disease (Orphanet):
- Inheritance
- X-linked dominant, X-linked recessive
- Onset
- Adolescent, Adult, Childhood
- Prevalence
- 1-9 / 1 000 000 (Worldwide)
Similar variants
- GLA p.Trp47Cys Likely pathogenic ★ same residue
- GLA p.Trp47Gly Pathogenic ★ same residue
- GLA p.Trp47Leu Likely pathogenic ★ same residue
- GLA p.Trp47Ter Pathogenic ★ same residue
- GLA p.Trp47fs Pathogenic ★ same residue
- GLA c.1000-10G>A Likely pathogenic ★★ same condition
- GLA c.1000-1G>A Pathogenic ★★ same condition
- GLA c.1000-1G>C Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gla-p-trp47arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown